Effects of Two Different Kinesio Taping Applications on Pain and Functional Mobility in Pregnants With Lumbopelvic Pain

March 14, 2023 updated by: İlkim Çıtak Karakaya, PT. PhD. Prof., Muğla Sıtkı Koçman University

Gebeliğe Bağlı Lumbopelvik Ağrıda İki Farklı Kinezyo Bant Uygulamasının Ağrı ve Fonksiyonel Mobilite Üzerine Etkisi

This study evaluates and compares the effects of two different kinesio taping applications on pain and functional mobility in pregnancy related lumbopelvic pain.

Study Overview

Detailed Description

Literature studies on the effectiveness of kinesio taping (KT) in pregnancy related lumbopelvic pain (LPP) are limited in number and have methodological shortcomings such as lack of randomization, a control group or assessor and/or patient blindness. Although generally presenting a significant effectiveness of KT on intensity of pain and disability, these parameters are evaluated by subjective methods, and the findings do not rely on quantitative data, in general.

In addition, the intervention parameters used in these studies, such as the KT techniques used, amount of KT tension and duration of the intervention are different from each other, and there is lack of studies comparing the effectiveness of different KT techniques.

In this study, effectiveness of two different KT applications will be compared with placebo KT:

  1. Lumbopelvic KT (LPKT): Two I-shaped kinesio tapes in 40 cm length will be applied bilaterally, beginning from 5 cm below the spina iliaca posterior superiors (SIPSs) to the level of the 12th costae, in maximum trunk flexion position, on the paravertebral muscles, by inhibition technique of muscle correction techniques. The tapes will be placed with no tension at 5 cm of both ends, and with 15-25% tension in between. In addition, an extra I-shaped tape will be placed perpendicullar to these tapes with the ligament correction technique, while the pregnant women are in the vertical upright position, at the level of the sacroiliac joints, starting with a tensile strength of 75-100% from the middle, and then with no tension at two ends.
  2. Abdominal supported LPKT (ALPKT): An abdominal support tape will be added to the LPKT. In order to reduce the tension of the uterus ligaments, and to help perception of the normal elasticity of the target tissues, ligament technique will be used. The middle part of an I-shaped tape will be placed to the midpoint of the lower abdomen, and then will be progressed laterally and above with 50% tension.

For placebo application, a Micropore™ surgical plaster of the same color with KT will be applied with no tension, as described in the LPKT technique.

All participants will undergo a 45-60 minutes of standard ergonomic education after initial assessments and following the first taping applications, They will be observed in regard to their behaviours during different activities such as standing, sitting, walking, turning in bed and standing from the bed. Necessary warnings will be given about correcting their posture and behaviors in terms of ergonomic principles.

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Zeynep Kamil Women's and Children's Disease Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • being able to read and write in Turkish,
  • being in 2nd or 3rd trimester of pregnancy,
  • having lumbar or pelvic girdle pain for at least one week
  • signing the informed consent form for the study

Exclusion Criteria:

  • visual, auditory or cognitive problems which may prevent participation to the study
  • health problems other than pregnancy related lumbopelvic pain (orthopedic, neurologic, cardiorespiratory, etc.) or trauma history, which may affect standing from sitting, walking or stair climbing activities
  • Any gynecological or urological problems which may mimic pregnancy related lumbopelvic pain
  • Any ddiagnosed pregnancy complications (preeclampsy, pregnancy related hypertension, diabetes, fetal anomaly, etc.)
  • Multiple gestation
  • History of spinal injury, ankylosing spondilitis, rheumatoid arthritis, intervertebral disc pathology
  • Positive straight leg raising test result or peripheral sensory or motor impairments which may indicate lumbar interbertebral disc pathology
  • History of prepregnancy low back pain
  • Using any analgesic or myorelaxant medication
  • Contraindications to KT (impaired skin integrity or lesion in the lumbopelvic and abdominal regions, history of allergic reaction, etc.)
  • previous KT experience

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Lumbopelvic kinesio taping (LPKT)
Two I-shaped kinesio tapes in 40 cm length will be applied bilaterally, beginning from 5 cm below the spina iliaca posterior superiors (SIPSs) to the level of the 12th costae, in maximum trunk flexion position, on the paravertebral muscles, by inhibition technique of muscle correction techniques. The tapes will be placed with no tension at 5 cm of both ends, and with 15-25% tension in between. In addition, an extra I-shaped tape will be placed perpendicullar to these tapes with the ligament correction technique, while the pregnant women are in the vertical upright position, at the level of the sacroiliac joints, starting with a tensile strength of 75-100% from the middle, and then with no tension at two ends.

Kinesio tapes applied to the lumbopelvic region will stay 3 days. They will be removed from the site, and the skin will be checked and cleaned, and then reapplied for the next 3 days.

An ergonomic education program will be given after the baseline measurements, and will last for 45-60 minutes. A brochure including ergonomic principles with images will also be provided.

Other Names:
  • Ergonomic education
Experimental: Abdominal supported lumbopelvic kinesio taping (ALPKT)
An abdominal support tape will be added to the LPKT. In order to reduce the tension of the uterus ligaments, and to help perception of the normal elasticity of the target tissues, ligament technique will be used. The middle part of an I-shaped tape will be placed to the midpoint of the lower abdomen, and then will be progressed laterally and above with 50% tension.

Kinesio tapes applied to the lumbopelvic region and abdominal area will stay 3 days. They will be removed from the sites, and the skin will be checked and cleaned, and then reapplied for the next 3 days.

An ergonomic education program will be given after the baseline measurements, and will last for 45-60 minutes. A brochure including ergonomic principles with images will also be provided.

Other Names:
  • Ergonomic education
Placebo Comparator: Placebo taping
A Micropore™ surgical plaster of the same color with KT will be applied with no tension, as described in the LPKT technique.

Placebo tapes (just like Kinesio tapes) applied to the lumbopelvic region without any tension will stay 3 days. They will be removed from the site, and the skin will be checked and cleaned, and then reapplied for the next 3 days.

An ergonomic education program will be given after the baseline measurements, and will last for 45-60 minutes. A brochure including ergonomic principles with images will also be provided.

Other Names:
  • Ergonomic education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain intensity during resting
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
Change in pain intensity during timed up and go (TUG) test
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
0 (no pain)-10 cm (unbearable pain) visual analogue scales will be used.
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
Change in pain intensity during five times sit to stand test
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
0 (no pain)-10 cm (unbearable pain) visual analogue scales will be used.
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
Change in pain intensity during stair climbing test
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
0 (no pain)-10 cm (unbearable pain) visual analogue scales will be used.
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
Change in time of completing timed up and go test (seconds)
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
All participants will perform the test from a chair (height: 46 cm) with back-support. They will be asked to stand up, walk three meters, turn around, walk back to the chair, and sit down as fast as they can. Time to complete the test will be recorded (sec). Lower times indicate better functional mobility level for walking.
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
Change in time of completing five times sit to stand test (seconds)
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
The participants will sit on a straight back chair (43 cm height) with arms folded across their chest. They will be instructed to stand up and sit down as quickly as possible 5 times, keeping their arms folded across their chest. Time for completing the test will be recorded (sec). Lower times indicate better functional mobility level for sit to stand activity.
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
Change in time of completing stair climbing test (seconds)
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
The participants will be asked to ascend and descend 10 stairs. Time of completing the test will be recorded in seconds. Lower times indicate better functional mobility level in stair activities
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in activity limitation
Time Frame: baseline, three days after the first taping, and one week after the first taping
Turkish version of Pelvic Girdle Questionnaire will be used. Total score of the questionnaire varies between 0 and 75, and higher scores indicate higher activity limitation.
baseline, three days after the first taping, and one week after the first taping

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 27, 2020

Primary Completion (Actual)

February 1, 2022

Study Completion (Actual)

June 22, 2022

Study Registration Dates

First Submitted

October 22, 2019

First Submitted That Met QC Criteria

October 23, 2019

First Posted (Actual)

October 25, 2019

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 14, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe